Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Lenvatinib and Thyroid cancer

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Lenvatinib and Thyroid cancer

Lenvatinib vs. Thyroid cancer

Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. Thyroid cancer is cancer that develops from the tissues of the thyroid gland.

Similarities between Lenvatinib and Thyroid cancer

Lenvatinib and Thyroid cancer have 4 things in common (in Unionpedia): Isotopes of iodine, Metastasis, RET proto-oncogene, VEGF receptor.

Isotopes of iodine

There are 37 known isotopes of iodine (53I) from 108I to 144I; all undergo radioactive decay except 127I, which is stable.

Isotopes of iodine and Lenvatinib · Isotopes of iodine and Thyroid cancer · See more »

Metastasis

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; it is typically spoken of as such spread by a cancerous tumor.

Lenvatinib and Metastasis · Metastasis and Thyroid cancer · See more »

RET proto-oncogene

The RET proto-oncogene encodes a receptor tyrosine kinase for members of the glial cell line-derived neurotrophic factor (GDNF) family of extracellular signalling molecules.

Lenvatinib and RET proto-oncogene · RET proto-oncogene and Thyroid cancer · See more »

VEGF receptor

VEGF receptors are receptors for vascular endothelial growth factor (VEGF).

Lenvatinib and VEGF receptor · Thyroid cancer and VEGF receptor · See more »

The list above answers the following questions

Lenvatinib and Thyroid cancer Comparison

Lenvatinib has 41 relations, while Thyroid cancer has 78. As they have in common 4, the Jaccard index is 3.36% = 4 / (41 + 78).

References

This article shows the relationship between Lenvatinib and Thyroid cancer. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »